Renaissance Technologies - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260508. A total of 19 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2019$123,000
-35.3%
310,885
+123.7%
0.00%
Q2 2019$190,000
-24.0%
138,984
+34.2%
0.00%
Q1 2019$250,000
+125.2%
103,574
+104.8%
0.00%
Q4 2018$111,00050,5740.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2019
NameSharesValueWeighting ↓
Integrated Wealth Concepts LLC 10,213$25,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 18,770$45,0000.00%
JANE STREET GROUP, LLC 11,858$29,0000.00%
UBS Group AG 6,588$16,0000.00%
DIMENSIONAL FUND ADVISORS LP 16,078$39,0000.00%
BANK OF AMERICA CORP /DE/ 257$1,0000.00%
WELLS FARGO & COMPANY/MN 300$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 10$00.00%
GEODE CAPITAL MANAGEMENT, LLC 16,399$39,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders